PRA was selected to perform a Phase II colorectal cancer trial due to our knowledge from previous colorectal studies as well as our evidence-based approach. In only a few months, our new client experienced PRA’s commitment open communication and engaging relationships and our determination to meet critical deadlines. These qualities are now the foundation of our very successful partnership.
Wearable Technology Introduces New Capabilities to Clinical Trials
Wearable devices are an essential part of our everyday lives. If you don’t own an Apple Watch or a Fitbit, chances are you know someone who does.…
Strategies for Accelerating Rare Disease Clinical Development
Rare disease trials differ from those in most other therapeutic areas because the indications are more complex and involve smaller patient…